elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35966191-0E29E083-6EC6-4147-880B-82C738576552
Q35966191-0E29E083-6EC6-4147-880B-82C738576552
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35966191-0E29E083-6EC6-4147-880B-82C738576552
Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer.
P2860
Q35966191-0E29E083-6EC6-4147-880B-82C738576552
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35966191-0E29E083-6EC6-4147-880B-82C738576552
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e9c31599c83c7dc26914004e73a7def4f9d126a0
P2860
Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522.